You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2003 R33 CA099136 PAR-01-104 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS SMALL MOLECULE MICROARRAYS FOR INTRACELLULAR PROTEINS Complete
2016 R33 CA202822 RFA-CA-15-005 SOKER, SHAY WAKE FOREST UNIVERSITY HEALTH SCIENCES BIOENGINEERED LUNG TUMOR ORGANOIDS FOR DEVELOPMENT OF PERSONALIZED MEDICINE Complete
2000 R33 CA088347 PAR-99-102 POOLA, INDIRA NONE HOWARD UNIVERSITY MOLECULAR ASSAY FOR ESTROGEN RECEPTORS IN BREAST TUMORS Complete
2018 R33 CA223904 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors NCE
2022 R33 CA258012 CA21-004 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic Control of Tumor Initiation and Tumor Progression in vivo Active
2004 R33 CA083208 PAR-01-106 SINGER, ROBERT H ALBERT EINSTEIN COL OF MED YESHIVA UNIV FISH AND CHIPS: SINGLE CELL EXPRESSION OF CANCER GENES Complete
2007 R33 CA114151 RFA-CA-07-001 MILOSAVLJEVIC, ALEKSANDAR BAYLOR COLLEGE OF MEDICINE MULTIPLEXED METHODS FOR THE STUDY OF CHROMOSOMAL ABERRATIONS IN CANCER Complete
2017 R33 CA204574 RFA-CA-16-002 KELLEY, SHANA O UNIVERSITY OF TORONTO Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis Complete
2021 R33 CA255893 RFA-CA-20-018 SEELIG, GEORG UNIVERSITY OF WASHINGTON Joint receptor and protein expression immunophenotyping through split-pool barcoding Active
2003 R33 CA101136 PAR-01-106 FURGE, KYLE A VAN ANDEL RESEARCH INSTITUTE COMPARATIVE GENOMIC ANALYSIS OF MICROARRAY DATA Complete
2013 R33 CA174575 RFA-CA-12-003 JI, HANLEE P STANFORD UNIVERSITY OLIGONUCLEOTIDE-SELECTIVE SEQUENCING FOR INTEGRATED AND RAPID CANCER GENOME ANALY Complete
2018 R33 CA225539 RFA-CA-17-011 JIANG, NING UNIVERSITY OF TEXAS, AUSTIN An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer Active
2007 R33 CA125520 RFA-CA-07-001 ROTHSTEIN, RODNEY J. COLUMBIA UNIVERSITY HEALTH SCIENCES USING SYNTHETIC DOSAGE LETHALITY TO SCREEN FOR NOVEL ANTI-TUMOR TARGETS Complete
2017 R33 CA204704 RFA-CA-16-002 WANG, YINGXIAO UNIVERSITY OF CALIFORNIA, SAN DIEGO Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells Complete
2021 R33 CA256102 RFA-CA-20-018 GREENBERG, JOEL DUKE UNIVERSITY Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens Active
2001 R33 CA081668 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2003 R33 CA103068 PAR-01-106 COLLINS, COLIN C UNIVERSITY OF CALIFORNIA SAN FRANCISCO DEVELOPMENT OF ESP: STRUCTURAL & FUNCTIONAL ONCOGENOMICS Complete
2000 R41 CA084688 PAR-98-066 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2000 R41 CA084693 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA Complete
2003 R41 CA103103 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2003 R41 CA103120 PAR-01-105 GUTHOLD, MARTIN NANOMEDICA, INC. NOVEL, SINGLE-MOLECULE APTAMER SELECTION METHOD Complete
2007 R41 CA128782 RFA-CA-07-011 CAO, HAN BIONANOMATRIX, INC. CONTINUOUS CHROMOSOME SORTING WITH MICRO/NANOFLUIDICS Complete
2006 R41 CA118625 RFA-CA-06-006 HIRSCHOWITZ, EDWARD A 20/20 GENESYSTEMS, INC. AUTO-ANTIBODY PROFILING OF NON-SMALL CELL LUNG CANCER Complete
1999 R41 CA081825 PAR-98-066 MACH, ROBERT H ANASAZI BIOMEDICAL RESEARCH, INC. SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION Complete
2001 R41 CA088384 PAR-99-101 SULK, ROBERTA A DELTANU, LLC ONE STEP H. PYLORI TEST--SCREENING AND INDIVIDUAL ASSAYS Complete
2000 R41 CA083369 PAR-98-066 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION Complete
2009 R42 CA140109 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2007 R42 CA116048 RFA-CA-07-011 RAMPERSAUD, ARFAAN COLUMBUS NANOWORKS, INC. COMMERCIALIZATION OF MAGNETIC NANOBEADS FOR CANCER CELL ENRICHMENT Complete
2010 R42 CA140109 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2008 R42 CA122715 RFA-CA-07-044 SAXENA, SATYA PRAKASH CALIBRANT BIOSYSTEMS, INC. VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS Complete
2006 R42 CA103103 RFA-CA-05-006 BAO, GANG VIVONETICS, INC. IN VIVO GENE DETECTION FOR CANCER ANALYSIS Complete
2002 R42 ES011746 PAR-99-101 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN BIOMARKER QUANTITATION Complete
2004 R42 CA084688 PAR-01-105 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2016 R43 CA203629 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2002 R43 CA096052 PAR-01-105 ISRAEL, BARBARA A. PLATYPUS TECHNOLOGIES, LLC OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS Complete
2015 R43 CA199211 PAR-13-327 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE Complete
1999 R43 CA081890 PAR-98-066 NERI, BRUCE P THIRD WAVE TECHNOLOGIES, INC. SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION Complete
2001 R43 CA092819 PAR-99-101 WANG, PENCHENG CALIBRANT BIOSYSTEMS, INC. 2-D MICROFLUIDIC GENE SCANNER Complete
2004 R43 CA105536 PAR-01-105 BECKER, CHRISTOPHER H SURROMED, INC. DIFFERENTIAL EXPRESSION MEASUREMENTS OF PHOSPHOPROTEOME Complete
2016 R43 CA203647 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2002 R43 CA096053 PAR-01-105 BECKER, CHRISTOPHER SURROMED, INC. AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING Complete
1999 R43 CA081891 PAR-98-066 WEAVER, DANIEL C GENOMICA CORPORATION ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY Complete
2001 R43 CA092826 PAR-99-101 WANG, JIWU ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INNOVATIVE RNA PROFILING IN CANCER CELLS Complete
2004 R43 CA105540 PAR-01-105 NIELSEN, ULRIK B. MERRIMACK PHARMACEUTICALS, INC. PRODUCTION OF ANTIBODIES SUITABLE FOR MICROARRAYS Complete
2016 R43 CA203681 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2000 R43 CA081787 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 CA096056 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
1999 R43 CA081903 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 CA093155 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete
2004 R43 CA105542 PAR-01-105 PARIS, MARK J VACCINEX, INC. FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS Complete

Pages